Unigrilin 20mg Injection

Unigrilin 20mg injection contains active components such as Eptifibatide. This medication is a medication used in the treatment of cardiovascular conditions. It belongs to a class of drugs known as glycoprotein IIb/IIIa inhibitors. It is primarily used in the management of acute coronary syndromes, including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI). It helps prevent platelet aggregation and blood clot formation within coronary arteries, thereby reducing the risk of further heart-related complications. This medication maintains blood flow within coronary arteries, reducing the chances of new clot formation or worsening of existing clots.

If you have a known hypersensitivity or allergic reaction to this medication, inform your healthcare provider before starting it. Patients with severe kidney disease should not take Unigrilin 20mg injection, as this medication is primarily cleared from the body through the kidneys. People with a history of intracranial bleeding, aortic dissection, or other conditions that could be worsened by anticoagulant therapy may need alternative treatment options. Individuals with a history of bleeding disorders, recent surgery, trauma, or other conditions that increase the risk of bleeding may require careful consideration before using this medication.